ClinicalTrials.Veeva

Menu

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value (RadioMucor)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Pulmonary Mucormycosis

Study type

Observational

Funder types

Other

Identifiers

NCT07339800
9767 (Other Identifier)

Details and patient eligibility

About

Invasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest imaging in their diagnosis is well established in the 2020 EORTC/MSGERC criteria, and its use is almost systematic. However, the progression of lung parenchymal involvement and any potential prognostic radiological patterns in the follow-up of these infections are less well understood. This research aims to identify imaging characteristics predictive of favorable or unfavorable outcomes in infected patients, in order to better tailor follow-up and therapeutic options.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years or older
  • Treated at Strasbourg University Hospital between January 1, 2009, and June 3, 2025
  • With a diagnosis of probable or proven invasive pulmonary infection with Mucorales according to the 2020 EORTC/MSGERC criteria
  • Having undergone at least one CT scan including the thoracic region

Exclusion criteria

  • No CT scan including the thoracic region
  • No diagnosis of probable or proven invasive pulmonary infection with Mucorales (EORTC/MSGERC 2020 criteria)

Trial contacts and locations

1

Loading...

Central trial contact

baptiste Hoellinger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems